Final AER Guidance Requires Full Address, Recommends Prefatory Language

In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs

More from Archive

More from HBW Insight